Barnaby F, Boeker E. (1999). „Is technetium-99 (Tc-99) radiologically significant?”. Med Confl Surviv. 15 (1): 57—70. PMID10218003. doi:10.1080/13623699908409425..
Cook, G. J.; Fogelman, I. (2001). „The role of nuclear medicine in monitoring treatment in skeletal malignancy”. Semin Nucl Med. 31 (3): 206—11. PMID11430527. doi:10.1053/snuc.2001.23527..
Yilmaz, M. H.; Ozguroglu, M.; Mert, D.; Turna, H.; Demir, G.; Adaletli, I.; Ulus, S.; Halac, M.; Kanberoğlu, K. (2008). „Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: A comparative study”. Med Oncol. 25 (3): 257—63. PMID18040900. S2CID20611870. doi:10.1007/s12032-007-9027-x.
Barnaby F, Boeker E. (1999). „Is technetium-99 (Tc-99) radiologically significant?”. Med Confl Surviv. 15 (1): 57—70. PMID10218003. doi:10.1080/13623699908409425..
Cook, G. J.; Fogelman, I. (2001). „The role of nuclear medicine in monitoring treatment in skeletal malignancy”. Semin Nucl Med. 31 (3): 206—11. PMID11430527. doi:10.1053/snuc.2001.23527..
Yilmaz, M. H.; Ozguroglu, M.; Mert, D.; Turna, H.; Demir, G.; Adaletli, I.; Ulus, S.; Halac, M.; Kanberoğlu, K. (2008). „Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: A comparative study”. Med Oncol. 25 (3): 257—63. PMID18040900. S2CID20611870. doi:10.1007/s12032-007-9027-x.
Yilmaz, M. H.; Ozguroglu, M.; Mert, D.; Turna, H.; Demir, G.; Adaletli, I.; Ulus, S.; Halac, M.; Kanberoğlu, K. (2008). „Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: A comparative study”. Med Oncol. 25 (3): 257—63. PMID18040900. S2CID20611870. doi:10.1007/s12032-007-9027-x.